肿瘤模型MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling.
期刊:Science (New York, N.Y.)发表年份:2007作者:Jeffrey A Engelman; Kreshnik Zejnullahu; Tetsuya Mitsudomi; Youngchul Song; Courtney Hyland; Joon Oh Park; Neal Lindeman; Christopher-Michael Gale; Xiaojun Zhao; James Christensen; Takayuki Kosaka; Alison J Holmes; Andrew M Rogers; Federico Cappuzzo;
